- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
DOBI Systems aquires $12 million financing
Privately held DOBI Medical Systems announced that it has arranged for $12 million in private equity with Sterling Financial Investment Group of Boca Raton, FL. The money will be used to further the engineering, design, and clinical testing of
Privately held DOBI Medical Systems announced that it has arranged for $12 million in private equity with Sterling Financial Investment Group of Boca Raton, FL. The money will be used to further the engineering, design, and clinical testing of DOBI's patented breast cancer diagnosis system.
The Dynamic Optical Breast Imaging (DOBI) system recently commenced clinical tests as an investigational device at a number of sites in the U.S.
The DOBI system will be used initially as an adjunct to traditional mammography. It operates by detecting the effects of increased vascularization (angiogenesis) associated with the growth of malignant lesions.
Emerging Perspectives on PSMA PET Radiotracers: An Interview with Kenneth J. Pienta, MD
April 24th 2024In a recent interview, Kenneth J. Pienta, M.D., discussed the impact of piflufolastat F18, current directions in research with other PSMA-targeted radiotracers and future possibilities for the role of PSMA PET in the imaging paradigm for prostate cancer.
Could a Newly FDA-Cleared C-Arm Device Bolster Efficiency for Interventional Radiologists?
April 22nd 2024In addition to advanced imaging quality and dose efficiency, the Philips Zenition 30 mobile C-arm device emphasizes personalized user profiles and automated customization to help reduce procedure time.
